Fluidigm Corporation
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consum… Read more
Fluidigm Corporation (FLB) - Total Assets
Latest total assets as of September 2025: €539.64 Million EUR
Based on the latest financial reports, Fluidigm Corporation (FLB) holds total assets worth €539.64 Million EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Fluidigm Corporation - Total Assets Trend (2015–2024)
This chart illustrates how Fluidigm Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Fluidigm Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
Fluidigm Corporation's total assets of €539.64 Million consist of 61.4% current assets and 38.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 27.2% |
| Accounts Receivable | €33.61 Million | 5.5% |
| Inventory | €40.74 Million | 6.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €28.95 Million | 4.7% |
| Goodwill | €111.30 Million | 18.2% |
Asset Composition Trend (2015–2024)
This chart illustrates how Fluidigm Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Fluidigm Corporation's current assets represent 61.4% of total assets in 2024, an increase from 38.9% in 2015.
- Cash Position: Cash and equivalents constituted 27.2% of total assets in 2024, up from 7.9% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, a decrease from 54.0% in 2015.
- Asset Diversification: The largest asset category is goodwill at 18.2% of total assets.
Fluidigm Corporation Competitors by Total Assets
Key competitors of Fluidigm Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Fluidigm Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Fluidigm Corporation generates 0.28x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Fluidigm Corporation is currently not profitable relative to its asset base.
Fluidigm Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.38 | 3.76 | 2.17 |
| Quick Ratio | 4.14 | 3.41 | 1.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €364.47 Million | € 332.99 Million | € 63.41 Million |
Fluidigm Corporation - Advanced Valuation Insights
This section examines the relationship between Fluidigm Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.08 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 89.5% |
| Total Assets | €612.34 Million |
| Market Capitalization | $35.49 Million USD |
Valuation Analysis
Below Book Valuation: The market values Fluidigm Corporation's assets below their book value (0.06 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Fluidigm Corporation's assets grew by 89.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Fluidigm Corporation (2015–2024)
The table below shows the annual total assets of Fluidigm Corporation from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €612.34 Million | +89.54% |
| 2023-12-31 | €323.07 Million | -17.23% |
| 2022-12-31 | €390.31 Million | +41.82% |
| 2021-12-31 | €275.21 Million | -15.26% |
| 2020-12-31 | €324.76 Million | +22.64% |
| 2019-12-31 | €264.81 Million | -12.79% |
| 2018-12-31 | €303.65 Million | +5.67% |
| 2017-12-31 | €287.35 Million | -6.22% |
| 2016-12-31 | €306.39 Million | -17.20% |
| 2015-12-31 | €370.05 Million | -- |